Frederick Luk
Impact in
- Molecular Medicine top 1%
- Curcumin's Biomedical Applications
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 6
- Oncology 8
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Mary Bebawy (15 shared papers)Richard Callaghan (1 shared paper)Wing‐Hin Lee (2 shared papers)Rebecca Sara Mason (2 shared papers)Judy Ching Yee Loo (2 shared papers)Ramin Rohanizadeh (3 shared papers)Ritu Jaiswal (7 shared papers)Georges E. Grau (5 shared papers)
- Journals
- Journal of Pharmacy & Pharmaceutical Sciences (1 paper)Drug Metabolism and Disposition (1 paper)Pharmacological Research (1 paper)Cancer Investigation (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- AustraliaUnited States
In The Last Decade
Frederick Luk
18 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Molecular Medicine 327
- Cancer Research 416
- Oncology 368
- Molecular Biology 940
- Pharmaceutical Science 83
Countries citing papers authored by Frederick Luk
This map shows the geographic impact of Frederick Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Luk more than expected).
Fields of papers citing papers by Frederick Luk
This network shows the impact of papers produced by Frederick Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Luk. The network helps show where Frederick Luk may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick Luk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 463 | |
| 2 | 2014 | 390 | |
| 3 | 2013 | 95 | |
| 4 | 2012 | 92 | |
| 5 | 2014 | 80 | |
| 6 | 2013 | 77 | |
| 7 | 2013 | 72 | |
| 8 | 2015 | 70 | |
| 9 | 2016 | 57 | |
| 10 | 2015 | 52 | |
| 11 | 2014 | 48 | |
| 12 | 2013 | 44 | |
| 13 | Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model. | 2011 | 37 |
| 14 | 2014 | 33 | |
| 15 | 2016 | 30 | |
| 16 | 2011 | 29 | |
| 17 | New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis. | 2011 | 4 |
| 18 | SYNTHESIS OF CURCUMIN NANOPARTICLES FOR LUNG CANCER THERAPY | 2014 | 1 |
About Frederick Luk
Frederick Luk is a scholar working on Cancer Research, Oncology, Molecular Medicine, Molecular Biology and Biomaterials, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Extracellular vesicles in disease (6 papers), Drug Transport and Resistance Mechanisms (6 papers), MicroRNA in disease regulation (6 papers), Nanoparticle-Based Drug Delivery (3 papers), Curcumin's Biomedical Applications (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Molecular Medicine (327 citations), Cancer Research (416 citations), Oncology (368 citations), Molecular Biology (940 citations) and Pharmaceutical Science (83 citations). Frederick Luk has collaborated with scholars based in Australia and United States. Frequent co-authors include Mary Bebawy, Richard Callaghan, Wing‐Hin Lee, Rebecca Sara Mason, Judy Ching Yee Loo, Ramin Rohanizadeh, Ritu Jaiswal, Georges E. Grau, Joyce Gong and Alison Thavary Ung. Their work appears in journals such as Journal of Pharmacy & Pharmaceutical Sciences, Drug Metabolism and Disposition, Pharmacological Research, Cancer Investigation and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.